This is the authors' abstract. We don't add key points for this paper.
A novel reusable silicon foil dosimeter based on the new emerging optically stimulated luminescence (OSL) material MgB4O7:Ce,Li (MBO) is developed and characterized for dosimetric verification of spatially resolved radiotherapy doses. Direct comparison of the spatial (two-2D towards three-3D) proton dose mapping can be achieved with an appropriately designed optical detection setup equipped with a light source (e.g., LEDs) that illuminates the dosimeter and a highly sensitive CCD camera that simultaneously acquires the 2D OSL light from the foil. The newly designed (2nd generation) optical setup allows the registration of high-resolution 2D proton doses (below 0.1 mm resolution) and reconstruction of the 2D proton dose distribution with an accuracy comparable to that of the GafchromicTM foils, the current standard of passive 2D dosimetry in radiotherapy. This article outlines the technology’s potential application with respect to the commercially available GafchromicTM EBT3 films in measurements of the clinically relevant, spatial proton dose mapping. The obtained comparison of the proton radial dose profiles (for EBT3 films vs MBO foils) agrees within 5%. The resulting image resolution (0.074 mm/px for MBO foil) corresponded well with the tested EBT3 films (0.085 mm/px), indicating excellent properties for future 3D proton dose verifications of modern radiotherapy techniques (e.g., proton radiotherapy).
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Sądel et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: